ISENTRESS (H.J. Harkins Company Inc.)
Welcome to the PulseAid listing for the ISENTRESS drug offered from H.J. Harkins Company Inc.. This HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | H.J. Harkins Company Inc. |
NON-PROPRIETARY NAME: | RALTEGRAVIR |
SUBSTANCE NAME: | RALTEGRAVIR POTASSIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-07-31 |
END MARKETING DATE: | 0000-00-00 |
ISENTRESS HUMAN PRESCRIPTION DRUG Details:
Item Description | ISENTRESS from H.J. Harkins Company Inc. |
LABELER NAME: | H.J. Harkins Company Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 2017-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 76519-1130_5554d179-32de-531e-e054-00144ff8d46c |
PRODUCT NDC: | 76519-1130 |
APPLICATION NUMBER: | NDA022145 |
Other RALTEGRAVIR POTASSIUM Pharmaceutical Manufacturers / Labelers: